Free tool
FAERS Monitor: Nitrous Oxide, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 206009 or its brand name (Nitrous Oxide, Usp, Nitrous Oxide). Reports on generic versions are filed under their own applications.
Reports
2,221
Serious
2,089
94% of reports
Hospitalization
835
Death reported
223
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug abuse142
- drug interaction133
- cardiac arrest122
- anaesthetic complication neurological117
- bradycardia101
- hypotension96
- toxicity to various agents90
- subacute combined cord degeneration84
- off label use67
- drug ineffective66
- drug dependence58
- hyperthermia malignant53
- vomiting53
- substance use52
- nausea51
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 100 |
| 2005 | 51 |
| 2007 | 39 |
| 2008 | 61 |
| 2009 | 74 |
| 2010 | 77 |
| 2011 | 45 |
| 2012 | 43 |
| 2013 | 100 |
| 2014 | 89 |
| 2015 | 107 |
| 2016 | 103 |
| 2017 | 130 |
| 2018 | 150 |
| 2019 | 128 |
| 2020 | 149 |
| 2021 | 230 |
| 2022 | 133 |
| 2023 | 114 |
| 2024 | 55 |
| 2025 | 139 |
| 2026 | 102 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,938 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| subacute combined cord degenerationSignal | 84 | 8749.5 | 6523.2 | 377,556 |
| anaesthetic complication neurologicalSignal | 117 | 1405.6 | 1162.7 | 141,796 |
| hyperthermia malignantSignal | 53 | 349.8 | 266.8 | 17,446 |
| substance useSignal | 52 | 326.6 | 248.5 | 16,007 |
| bradycardiaSignal | 101 | 18.1 | 14.9 | 1,613 |
| drug abuseSignal | 142 | 16.2 | 13.8 | 2,012 |
| cardiac arrestSignal | 122 | 14.0 | 11.8 | 1,465 |
| drug interactionSignal | 133 | 7.9 | 6.7 | 806 |
| toxicity to various agentsSignal | 90 | 5.1 | 4.1 | 291 |
| hypotensionSignal | 96 | 4.5 | 3.7 | 263 |
| drug dependenceSignal | 58 | 3.4 | 2.7 | 97 |
| vomiting | 53 | 1.1 | 0.8 | 0 |
| off label use | 67 | 0.7 | 0.6 | 7 |
| nausea | 51 | 0.6 | 0.5 | 13 |
| drug ineffective | 66 | 0.5 | 0.4 | 40 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.